2013 Three-Part Symposium Schedule

 

Friday December 6, 2013
7:30 AM-8:00 AM - Registration

Part 1: Hepatocellular Carcinoma (HCC): Specialized Sessions
(See below for more details)

8:00 AM-12:00 PM - Specialized Sessions
12:00 PM-1:00 PM - Lunch

Part 2: Molecular Profiling in Cancer: Research or Practice? Main event

1:00 PM-2:15 PM - Molecular Profiling 101
  • Michael A. Pacanowski, Pharm.D., M.P.H.
    Associate Director, Genomics and Targeted Therapy, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, FDA
  • Chip Petricoin, PhD
    Co-Director, Center for Applied Proteomics & Molecular Medicine, Professor of Life Sciences, George Mason University
  • Gary Palmer, MD, JD, MBA, MPH
    Senior Vice President of Foundation Medicine, Medical Affairs and Commercial Development
  • Jeffrey Roche, MD, MPH
    Lead Medical Officer, Centers for Medicare and Medicaid Services, Coverage Analysis Group

2:15 PM-3:15 PM - Schafer Lecture

Manuel Hidalgo, MD, PhD
Associate Professor of Oncology, Johns Hopkins University School of Medicine; Director, Centro Integral Oncológico Clara Campal (CIOCC), Madrid, Spain

The Thomas R. Schafer Memorial Lecture Fund for Research and Education in Pancreatic and Gastrointestinal Cancer was established in 1999 as a tribute by the late Thomas Schafer's family and friends. They felt strongly that his spirit should live on through this fund for an annual lectureship, designed to discuss the latest concepts and innovations in cancer therapy.


3:15 PM-3:30 PM - Break
3:30 PM-5:00 PM - Profiling in Practice - Case Study Presentations
  • Moderator – TBA
  • Hartmut Juhl. MD
    Associate Professor for Oncology and Surgery at Georgetown University; Founder and Chief Executive Officer, Indivumed
  • Ira Klein, MD, MBA
    Senior Medical Director, National Accounts Clinical Sales and Strategy, Aetna
  • Joe V. Selby, MD, MPH
    Executive Director of Patient-Centered Outcomes Research Institute
  • Gilad Gordon, MD, MBA
    President, Orra Group, LLC; Clinical Associate Professor, University of Colorado Denver
  • Mace Rothenberg, MD
    Senior VP, Clinical Development and Medical Affairs, Oncology Business Unit, Pfizer, Inc.

 

Details of Specialized Sessions:

  • Epidemiology and Surveillance for HCC
  • Biomarkers for HCC subsets
  • Risk factors for HCC: NASH and chemoprevention
  • Biology and therapeutic targets for liver cancer
  • Treatment for early stage HCC
  • Treatment for intermediate stage HCC
  • Management for advanced HCC beyond Sorafenib
  • Multidisciplinary approach to HCC including treatment of hepatitis

 


Saturday December 7, 2013
9:30 AM-10:00 AM - Registration

Part 3: Patient Symposium

10:00 AM-11:15 AM - Disease Specific Breakout Sessions
      • Pancreatic Cancer, Presenter: Pancreatic Cancer Action Network
      • Colon Cancer, Presenter: Chris4Life
      • Liver Cancer, Presenter: American Liver Foundation
      • Stomach Cancer, Presenter: Debbie's Dream Foundation

11:15 AM-12:15 PM - Key Note: Genetic Privacy
12:15 PM-1:00 PM - Lunch
1:00 PM- 2:30 PM - Topical Breakout Sessions (Participants pick two)
  • Legal and Insurance Issues:
    Juliette Espinosa, MA, JD, LL.M.
    Founder and Director of Health Care Rights Initiative

  • Maintaining and Improving Relationships: Sexuality, Intimacy and Communication Nutrition:
    Sage Bolte, PhD, LCSW, OSW-C
    Oncology Counselor; Program Coordinator, Inova Fair Oaks, Life with Cancer

    Julia Rowland, PhD
    Director Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH/DHHS

  • Nutrition:
    Rachel Wong, RD, CSO, LD
    Outpatient Oncology Dietitian at Georgetown Lombardi Comprehensive Cancer Center

  • Pain Management/Palliative Care:
    Derek Thompson, MD
    MedStar Georgetown University Hospital

  • Organizing Cancer Care:
    Geoff Hackman, Caregiver
    Paul Leleck, Caregiver

  • Meditation:
    Presenter: Hope Connections for Cancer Support